US EditionPublished • loading... • Updated
Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies
Summary by Globe Newswire
6 Articles
6 Articles
Globe Newswire+5 Reposted by 5 other sources
Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies
Dr. Andreas Wallnöfer joins the board of Optigo Biotherapeutics – the ophthalmology company pioneering next-gen treatments for retinal diseases....
Coverage Details
Total News Sources6
Leaning Left5Leaning Right0Center1Last UpdatedBias Distribution83% Left
Bias Distribution
- 83% of the sources lean Left
83% Left
L 83%
C 17%
Factuality
To view factuality data please Upgrade to Premium
